✦ LIBER ✦

Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis

✍ Scribed by Nikolas Tsavaris; Nicolaos Kavantzas; Kostantinos Tsigritis; Ioannis D Xynos; Nikitas Papadoniou; Andreas Lazaris; Christos Kosmas; George Agrogiannis; Anna Dokou; Evangelos Felekouras; Efstathios Antoniou; Aris Polyzos; John Sarantonis; Heracles Tsipras; Gavrilos Karatzas; Alexandros Papalambros; Efstratios S Patsouris

Book ID: 115011641
Publisher: BioMed Central
Year: 2009
Tongue: English
Weight: 858 KB
Volume: 9
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-9-264

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors in patients with unre

Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation

✍ Sunil Krishnan; Vishal Rana; Nora A. Janjan; James L. Abbruzzese; Morris S. Goul 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

A multicenter analysis of GTX chemothera

A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma

✍ Ana De Jesus-Acosta; George R. Oliver; Amanda Blackford; Katharine Kinsman; Edna 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 361 KB

Retrospective trial of concurrent gemcit

Retrospective trial of concurrent gemcitabine (GEM) or infusional 5-fluoruracil (5-FU), folinic acid (FA), interferon (IFN) treatment in patients with locally advanced or metastatic pancreatic adenocarcinoma

✍ Eickhoff, Axel S.; Jakobs, Ralf; Riemann, Juergen F. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Locally advanced non-metastatic breast c

Locally advanced non-metastatic breast cancer: Analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach

✍ G. Gardin; R. Rosso; E. Campora; L. Repetto; C. Naso; G. Canavese; A. Catturich; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 679 KB

Phase II study of nimotuzumab, a humaniz

Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer

✍ Dirk Strumberg, Beate Schultheis, M. E. Scheulen, R. A. Hilger, J. Krauss, N. Ma 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 144 KB

P-438 A retrospective analysis of progno

P-438 A retrospective analysis of prognostic factors and rreatment outcomes of different chemotherapy regimens in patients with locally advanced (Stage IIIB) and metastatic (Stage IV) non-small cell lung cancer (NSCLC): A single Egyptian institution's experience

✍ Azim, H.A.; Moneim, D.A.; Kamal, N.; Raouf, M.; Kamel, Y.M. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 265 KB